New ways to help people avoid opioid overdose and beat addiction
This is just one example of how Yale School of Medicine researchers and clinicians are pursuing innovations that could both improve treatment of opioid addiction and introduce new painkillers that are effective yet not addictive.Source: Yale Medicine
Nav1.7: a new channel for pain treatment
Following intriguing genetic discoveries in people with extreme sensitivity to pain, as well as some families who feel no pain at all, researchers and drug companies are optimistic that blocking a sodium channel called Nav1.7 may lead to a new generation of more sophisticated painkillers. Meanwhile, however, there is still debate about the underlying mechanism of Nav1.7 in pain.Source: The Pharmaceutical Journal
In a world of chronic pain, individual treatment possible, Yale research shows
An investigation into the molecular causes of a debilitating condition known as “Man on Fire Syndrome” has led Yale researchers to develop a strategy that may lead to personalized pain therapy and predict which chronic pain patients will respond to treatment.
Yale team discovers unexpected source of diabetic neuropathy pain
Nearly half of all diabetics suffer from neuropathic pain, an intractable, agonizing and still mysterious companion of the disease. Now Yale researchers have identified an unexpected source of the pain and a potential target to alleviate it.
Yale Researchers Uncover Source of Mystery Pain
An estimated 20 million people in the United States suffer from peripheral neuropathy, marked by the degeneration of nerves and in some cases severe pain. There is no good treatment for the disorder and doctors can find no apparent cause in one of every three cases.
Inpatient Milieu Therapy: Considerations for Adolescent and Transitional Age Youth
The role of milieu therapy on inpatient treatment has become more prominent due to the changing landscape of hospital care, with shorter length of stay, higher patient acuity, and rapid turnover, writes Yale Psychiatry researchers.Source: Adolescent Psychiatry
Dr. Emily Gilmore & ELECTRO-BOOST Team Awarded $3.25M NINDS Grant
Principal Investigators Dr. Emily Gilmore, MD (Yale), Dr. Kan Ding, MD (UTSW), and Dr. Eric Rosenthal, MD (Massachusetts General Hospital) have received a $3.25 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) for their project entitled: "ELECTRO-BOOST: Electroencephalography for cerebral trauma recovery and oxygenation."
Health officials ramp up effort to convince public that vaccine decisions will be based on science, not politics
As officials race to stop the pandemic, they are increasingly worried that public skepticism could spur a substantial number of people to reject a vaccine, undermining the nation’s ability to return to some semblance of normal life. But the FDA’s efforts to convince the public the agency will make sound, data-driven decisions have been complicated by the White House’s politicization of health and science issues.Source: Washington Post
U.S. Broadens Attack on Chinese Internet Giants With WeChat Order
The Trump administration is widening its attack against Chinese internet giants by targeting a social media app, WeChat, that is used daily by ordinary Chinese but by few Americans, further cementing a divide in the global internet.Source: Wall Street Journal